Imran Khan, the founder of Pakistan Tehreek-e-Insaf (PTI), underwent a critical follow-up eye procedure late on February 23, 2026.
Read More: https://theboardroompk.com/ufone-and-zong-deposit-30m-pre-bid-for-pakistans-5g-auction/
He was shifted from Adiala Jail to the Pakistan Institute of Medical Sciences (PIMS) in Islamabad for the treatment.
The former prime minister received his second dose of an anti-VEGF intravitreal injection to manage severe Central Retinal Vein Occlusion (CRVO) in his right eye.
Medical Details and Treatment Progress
Doctors diagnosed CRVO, which has caused about 85% vision loss in the affected eye. The condition blocks blood flow in the retina and requires prompt intervention to prevent permanent damage.
The first injection was administered on January 24-25, 2026.
This second dose was given as day-care surgery under senior ophthalmologists and vitreo-retinal surgeons from PIMS and Al-Shifa Eye Hospital. A medical board examined him beforehand. Cardiac tests, including ECG and echocardiography, returned normal results.
Political Reactions and Concerns
PTI Chairman Barrister Gohar Ali Khan criticized the lack of transparency and independent oversight.
He demanded inclusion of personal physicians in future examinations and suggested transfer to a private facility like Shifa International Hospital. The Tehreek-e-Tahaffuz-e-Aaeen-e-Pakistan (TTAP) condemned the night time transfer without family or party consultation, labelling it a violation of rights.
Hospital officials confirmed the procedure’s success and declared Imran Khan clinically stable. He was returned to Adiala Jail under heavy security after the treatment. The third and final injection in this course is tentatively scheduled for March 23, 2026.